In adults exposed to COVID-19, hydroxychloroquine did not reduce confirmed or probable COVID-19; trial stopped for futility.

Singh, Ameeta; Sonpar, Ashlesha

Singh, Ameeta; Sonpar, Ashlesha.

Singh A; University of Alberta, Edmonton, Alberta, Canada (A.S., A.S.).
Sonpar A; University of Alberta, Edmonton, Alberta, Canada (A.S., A.S.).

Ann Intern Med ; 173(8): JC41, 2020 10 20.

Article in English | MEDLINE | ID: covidwho-881504

ABSTRACT

ABSTRACT

SOURCE CITATION Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med. 2020;383517-25. 32492293.

Subject(s)

Coronavirus Infections; Hydroxychloroquine; Medical Futility; Pandemics; Pneumonia, Viral; Adult; Betacoronavirus; COVID-19; Coronavirus Infections/drug therapy; Humans; Hydroxychloroquine/adverse effects; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Medical Futility / Pandemics / Hydroxychloroquine Type of study: Experimental Studies / Randomized controlled trials Limits: Adult / Humans Language: English Journal: Ann Intern Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google